CRISPR/Cas9 technology has enabled the application of new therapeutic approaches to treating disease in animal models, some of which are beginning to be seen in the first human clinical trials.

Beyond gene editing, the CRISPR–Cas9 technology offers a versatile sequence-specific gene regulation 'toolset', by utilizing the nuclease-deficient dCas9, which was designed not to cleave DNA ...

We are honored to help more firms and researchers commercialize CRISPR/Cas9 technology with officially validated gene-editing licenses, enhancing global innovation with broader applications of ...

CRISPR/Cas9 technology to inactivate cancer mutations, say scientists Date: August 31, 2016 Source: Technische Universität Dresden Summary: As for many other biomedical and biotechnology ...

By pairing the CRISPR/Cas9 system with a programmable DNA-binding domain (CRISPR/Cas9-pDBD), a researcher has developed a new technology platform that is precise enough to surgically edit DNA at ...

The application broadly encompassed CRISPR-Cas9 genome-editing technology invented by the Doudna-Charpentier team and its applications in any setting, UC said, including in vitro, and cellular and ...

Scientists study a molecular machine that moves jumping genes in DNA, paving the way for a new gene editing tool beyond ...

To remove background noise, Jumpcode Genomics has developed a technology called CRISPRclean™ that harnesses the specificity of CRISPR-Cas9 to remove unwanted sequences from NGS libraries.

Scientists have used CRISPR-Cas9 technology to develop therapies for genetic disorders relatively easily and cost-effectively. In this article, explore the milestones in CRISPR therapy development, ...

CRISPR-Cas9 Genome Editing Technology - ERS Genomics CRISTARS Gene Editing Technology Innovation Platform- BRL Medicine Gene Editing-BDmRNA Platform Shanghai BDgene ...

NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

The global CRISPR-based gene editing market size is projected to grow from USD 4.46 billion in 2025 to over USD 13.39 billion by 2034, expanding at a CAGR of 13%. Growth is fueled by advancements in ...